mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
KIN001-102 |
GDSC1000 |
pan-cancer |
AAC |
0.016 |
0.6 |
mRNA |
PF-750 |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
C6-ceramide |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.6 |
mRNA |
PLX4720 |
GDSC1000 |
pan-cancer |
AAC |
-0.016 |
0.6 |
mRNA |
GSK2126458 |
GDSC1000 |
pan-cancer |
AAC |
0.017 |
0.6 |
mRNA |
JQ-1:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
BRD-K99584050 |
CTRPv2 |
pan-cancer |
AAC |
0.027 |
0.6 |
mRNA |
GSK-J4 |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.6 |
mRNA |
KIN001-260 |
GDSC1000 |
pan-cancer |
AAC |
-0.016 |
0.6 |